Jean L. Grem
Experienced in Childhood Acute Myeloid Leukemia

Dr. Jean L. Grem

Hematology Oncology | Oncology
Unmc Physicians
987400 Nebraska Medical Ctr, Unmc Physicians Nebraska Me, 
Omaha, NE 
Accepting New Patients
Offers Telehealth
Experienced in Childhood Acute Myeloid Leukemia
Unmc Physicians
987400 Nebraska Medical Ctr, Unmc Physicians Nebraska Me, 
Omaha, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jean Grem is a Hematologist Oncology specialist and an Oncologist in Omaha, Nebraska. Dr. Grem and is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, and Pancreaticoduodenectomy. Dr. Grem is currently accepting new patients.

Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in NE
Hospital Affiliations
Bellevue Medical Center, LLC
The Nebraska Medical Center
Languages Spoken
English
American Sign Language
Sign Language
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Wellmark
  • HMO
  • POS

Locations

UNMC PHYSICIANS
987400 Nebraska Medical Ctr, Unmc Physicians Nebraska Me, Omaha, NE 68198
Other Locations
UNMC PHYSICIANS
111 N 175th St, Omaha, NE 68118

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other, Dietary supplement, Drug
Study Drugs: Bevacizumab, Oxaliplatin, Leucovorin calcium, Fluorouracil, Irinotecan hydrochloride, Irinotecan
Study Phase: Phase 3
A Phase 1b Dose-escalation Study of the Safety and Pharmacokinetics of Fixed-dose PCS6422 with Escalating Doses of Capecitabine Administered Orally to Patients with Advanced, Refractory Gastrointestinal Tract Tumors
A Phase 1b Dose-escalation Study of the Safety and Pharmacokinetics of Fixed-dose PCS6422 with Escalating Doses of Capecitabine Administered Orally to Patients with Advanced, Refractory Gastrointestinal Tract Tumors
Enrollment Status: Completed
Publish Date: October 10, 2024
Intervention Type: Drug
Study Drugs: Eniluracil, Capecitabine
Study Phase: Phase 1
A Phase IIa (Pilot) Study of Neoadjuvant Chemotherapy With Folinic Acid, 5-FU, Irinotecan and Oxaliplatin (FOLFIRINOX) With Digoxin in Patients With Resectable Pancreatic Cancer
A Phase IIa (Pilot) Study of Neoadjuvant Chemotherapy With Folinic Acid, 5-FU, Irinotecan and Oxaliplatin (FOLFIRINOX) With Digoxin in Patients With Resectable Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drugs: Digoxin, 5Fluorouracil, Calcium Leucovorin, Irinotecan, Oxaliplatin
Study Phase: Phase 2
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2024
Intervention Type: Procedure, Other, Drug
Study Phase: Phase 2/Phase 3
A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients
A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients
Enrollment Status: Completed
Publish Date: January 03, 2024
Intervention Type: Genetic, Other, Drug
Study Phase: Phase 1
A Phase I Study of ADH-1 and Gemcitabine Plus Cisplatin in Patients With Unresectable or Metastatic Pancreatic and Biliary Tract Cancers
A Phase I Study of ADH-1 and Gemcitabine Plus Cisplatin in Patients With Unresectable or Metastatic Pancreatic and Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: December 28, 2023
Intervention Type: Drug, Other
Study Phase: Phase 1
A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid Tumors
A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid Tumors
Enrollment Status: Completed
Publish Date: December 26, 2023
Intervention Type: Drug, Genetic, Other
Study Phase: Phase 1
A Phase II Study of Neo-adjuvant Therapy With Oxaliplatin, Leucovorin, 5-Fluorouracil, Panitumumab (Vectibix) and Radiation in Patients With Locally Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction
A Phase II Study of Neo-adjuvant Therapy With Oxaliplatin, Leucovorin, 5-Fluorouracil, Panitumumab (Vectibix) and Radiation in Patients With Locally Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Enrollment Status: Terminated
Publish Date: October 26, 2023
Intervention Type: Biological, Drug, Other, Procedure, Radiation
Study Phase: Phase 2
Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients With Refractory Metastatic Colorectal Cancer (mCRC)
Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients With Refractory Metastatic Colorectal Cancer (mCRC)
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Other, Drug
Study Drugs: Clobetasol propionate, Regorafenib
Study Phase: Phase 2
View 8 Less Clinical Trials

40 Total Publications

NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 16, 2024
Similar Doctors
Distinguished in Childhood Acute Myeloid Leukemia
Dr. Lori J. Maness-Harris
Hematology Oncology | Hematology
Distinguished in Childhood Acute Myeloid Leukemia
Dr. Lori J. Maness-Harris
Hematology Oncology | Hematology

Unmc Physicians

987400 Nebraska Medical Ctr, Unmc Physicians Nebraska Me, 
Omaha, NE 
 (0.1 mi)
402-559-4000
Languages Spoken:
English, American Sign Language, Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Lori Maness-Harris is a Hematologist Oncology specialist and a Hematologist in Omaha, Nebraska. Dr. Maness-Harris and is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Maness-Harris is currently accepting new patients.

Vijaya R. Bhatt
Distinguished in Childhood Acute Myeloid Leukemia
Dr. Vijaya R. Bhatt
Hematology Oncology | Oncology | Hematology
Distinguished in Childhood Acute Myeloid Leukemia
Dr. Vijaya R. Bhatt
Hematology Oncology | Oncology | Hematology

Unmc Physicians

Emile 42nd St, 
Omaha, NE 
 (0.1 mi)
402-559-4015
Experience:
16+ years
Languages Spoken:
English, American Sign Language, Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Vijaya Bhatt is a Hematologist Oncology specialist and an Oncologist in Omaha, Nebraska. Dr. Bhatt has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhatt is currently accepting new patients.

Advanced in Childhood Acute Myeloid Leukemia
Dr. Krishna Gundabolu
Hematology Oncology | Hematology | Oncology
Advanced in Childhood Acute Myeloid Leukemia
Dr. Krishna Gundabolu
Hematology Oncology | Hematology | Oncology

Unmc Physicians

Emile 42nd St, 
Omaha, NE 
 (0.1 mi)
402-559-4015
Languages Spoken:
English, American Sign Language, Hindi, Sign Language, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Krishna Gundabolu is a Hematologist Oncology specialist and a Hematologist in Omaha, Nebraska. Dr. Gundabolu and is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Their top areas of expertise are Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Venous Thromboembolism (VTE), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gundabolu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grem's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile